Pifithrin-alpha decreases the radioprotective efficacy of a Podophyllum hexandrum Himalayan mayapple fraction REC-2006 in HepG2 cells

Biotechnol Appl Biochem. 2009 Jul 9;54(1):53-64. doi: 10.1042/BA20080250.

Abstract

Inhibition of the tumour suppressor p53 by PFT (pifithrin-alpha) promotes p53-mediated apoptosis and protects against doxorubicin-induced apoptosis. The present study was carried out to evaluate the effect of PFT on the radioprotective potential of Podophyllum hexandrum fraction (REC-2006) in HepG2 (p53++) cell line. REC-2006 (10-5 microg/ml) treatment at 2 h before irradiation (10 Gy) rendered 80+/-3% protection in HepG2 cells, whereas PFT debilitated the radioprotective potential of REC-2006. REC-2006 increased the expression of Hsp70 (heat-shock protein 70), HSF1 (heat-shock factor 1) and Bcl-2 in irradiated HepG2 cells, whereas PFT when treated with REC-2006 decreased the expression of Hsp70, HSF1 and Bcl-2 in HepG2 cells. REC-2006 facilitated post-irradiation DNA repair by pausing cell-cycle progression at G1- and G2-phase, whereas no such cell-cycle arrest was observed in irradiated HepG2 cells pretreated with PFT in irradiated HepG2 cells. No change was observed in Mdm2 (murine double minute 2) and Ras-GAP (Ras-GTPase-activating protein) expression with or without PFT treatment. Decrease in the expression of caspase 3 and Bax was observed in HepG2 cells when REC-2006 treatment was given 2 h before irradiation; however, PFT treatment increased the expression of Bax leading to apoptosis. It can be concluded that p53 expression plays a major role in the REC-2006-mediated protection against acute irradiation in HepG2 cells. PFT treatment reduced the radioprotective efficacy of REC-2006 by inhibiting the expression of HSF1 and Hsp70 and thereby the expression of Bcl-2, by up-regulating the cell-cycle-regulatory proteins and therefore reducing the span of time for DNA repair and also by inducing Bax-mediated apoptosis. PFT did not, however, show any effect on p53 regulating protein (Mdm2) and pro-survival protein (Ras-GAP).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins / metabolism
  • Benzothiazoles / pharmacology*
  • Cell Cycle Proteins / biosynthesis
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • DNA, Neoplasm / radiation effects
  • DNA-Binding Proteins / biosynthesis
  • Drug Interactions
  • HSP70 Heat-Shock Proteins / biosynthesis
  • Heat Shock Transcription Factors
  • Humans
  • Plant Extracts / pharmacology*
  • Podophyllum / chemistry*
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-mdm2 / biosynthesis
  • Radiation-Protective Agents / pharmacology*
  • Toluene / analogs & derivatives*
  • Toluene / pharmacology
  • Transcription Factors / biosynthesis
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / biosynthesis
  • ras GTPase-Activating Proteins / biosynthesis

Substances

  • Apoptosis Regulatory Proteins
  • Benzothiazoles
  • Cell Cycle Proteins
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • HSF1 protein, human
  • HSP70 Heat-Shock Proteins
  • Heat Shock Transcription Factors
  • Plant Extracts
  • Proto-Oncogene Proteins c-bcl-2
  • Radiation-Protective Agents
  • TP53 protein, human
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • ras GTPase-Activating Proteins
  • Toluene
  • pifithrin
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2